title: Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor.
authors.affiliation: Helsinki University Hospital, Helsinki, Finland; Oncology Analytics, Plantation, FL; Sutter Healthcare System, San Francisco, CA; William Jennings Bryan Dorn Veterans Administration Medical Center; South Carolina College of Pharmacy, the University of South Carolina, Columbia; and the Hollings Cancer Center, Charleston, SC.
authors.forename: Terhi T O
authors.initials: TT
authors.lastname: Hermanson
authors.affiliation: Helsinki University Hospital, Helsinki, Finland; Oncology Analytics, Plantation, FL; Sutter Healthcare System, San Francisco, CA; William Jennings Bryan Dorn Veterans Administration Medical Center; South Carolina College of Pharmacy, the University of South Carolina, Columbia; and the Hollings Cancer Center, Charleston, SC.
authors.forename: William J
authors.initials: WJ
authors.lastname: Hrushesky
authors.affiliation: Helsinki University Hospital, Helsinki, Finland; Oncology Analytics, Plantation, FL; Sutter Healthcare System, San Francisco, CA; William Jennings Bryan Dorn Veterans Administration Medical Center; South Carolina College of Pharmacy, the University of South Carolina, Columbia; and the Hollings Cancer Center, Charleston, SC.
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Knopf
authors.affiliation: Helsinki University Hospital, Helsinki, Finland; Oncology Analytics, Plantation, FL; Sutter Healthcare System, San Francisco, CA; William Jennings Bryan Dorn Veterans Administration Medical Center; South Carolina College of Pharmacy, the University of South Carolina, Columbia; and the Hollings Cancer Center, Charleston, SC charlesleebennett@gmail.com.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000009:adverse effects* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab